CureZone   Log On   Join

Re: "The Closest Thing to The Fountain of Youth Yet Discovered" by Quinta_Essentia ..... Alzheimer’s Disease Forum

Date:   2/11/2009 9:25:15 PM ( 12 years ago ago)
Hits:   11,605

1 of 2 (50%) readers agree with this message.  Hide votes     What is this?

fascinating, thanks for posting that. i looked for more info and found this. it clearly shows that a pantethine metabolite (pantethine is aka vitamin B5) called cystamine does increase BDNF.

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

Borrell-Pagès M, Canals JM, Cordelières FP, Parker JA, Pineda JR, Grange G, Bryson EA, Guillermier M, Hirsch E, Hantraye P, Cheetham ME, Néri C, Alberch J, Brouillet E, Saudou F, Humbert S.

Institut Curie, CNRS UMR 146, Orsay, France.

There is no treatment for the neurodegenerative disorder Huntington disease (HD). Cystamine is a candidate drug; however, the mechanisms by which it operates remain unclear. We show here that cystamine increases levels of the heat shock DnaJ-containing protein 1b (HSJ1b) that are low in HD patients. HSJ1b inhibits polyQ-huntingtin-induced death of striatal neurons and neuronal dysfunction in Caenorhabditis elegans. This neuroprotective effect involves stimulation of the secretory pathway through formation of clathrin-coated vesicles containing brain-derived neurotrophic factor (BDNF).

Cystamine increases BDNF secretion from the Golgi region that is blocked by reducing HSJ1b levels or by overexpressing transglutaminase. We demonstrate that cysteamine, the FDA-approved reduced form of cystamine, is neuroprotective in HD mice by increasing BDNF levels in brain. Finally, cysteamine increases serum levels of BDNF in mouse and primate models of HD. Therefore, cysteamine is a potential treatment for HD, and serum BDNF levels can be used as a biomarker for drug efficacy.

<< Return to the standard message view

fetched in 0.11 sec, referred by